KR102235623B1 - Health care food and method for manufacturing thereof - Google Patents
Health care food and method for manufacturing thereof Download PDFInfo
- Publication number
- KR102235623B1 KR102235623B1 KR1020200104750A KR20200104750A KR102235623B1 KR 102235623 B1 KR102235623 B1 KR 102235623B1 KR 1020200104750 A KR1020200104750 A KR 1020200104750A KR 20200104750 A KR20200104750 A KR 20200104750A KR 102235623 B1 KR102235623 B1 KR 102235623B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- extract
- concentrate
- black ginseng
- fish collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/40—Preservation of foods or foodstuffs, in general by heating loose unpacked materials
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
-
- A23L3/16—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Microbiology (AREA)
Abstract
Description
본 발명은 건강보조식품 및 그 제조방법에 관한 것으로, 더욱 상세하게는 항염 및 항산화 활성이 우수한 체리의 농축액과 흑삼의 농축액을 건강보조식품으로 제조함으로써, 체리와 흑삼의 각종 영양성분 및 약용성분의 꾸준한 섭취가 가능하도록 하는 건강보조식품 및 그 제조방법에 관한 것이다. The present invention relates to a health supplement and a method for manufacturing the same, and more particularly, by preparing a concentrate of cherry and black ginseng having excellent anti-inflammatory and antioxidant activity as health supplements, various nutrients and medicinal ingredients of cherry and black ginseng are prepared. It relates to a health supplement that enables steady intake and a method of manufacturing the same.
최근 생활수준이 높아지고 식생활이 서구화되면서 영양과잉, 운동부족 등으로 인한 비만, 당뇨, 고혈압 및 심장병 등과 같은 생활 습관병(성인병) 발병이 높아지고 있다. 또한, 평균수명 연장으로 인한 노령화 사회로의 진입 속도가 빨라지면서 건강증진에 대한 관심이 높아지고 있다.Recently, as the standard of living has increased and the diet has become westernized, the incidence of lifestyle-related diseases (adult diseases) such as obesity, diabetes, high blood pressure and heart disease due to excess nutrition and lack of exercise is increasing. In addition, as the speed of entry into an aging society is accelerating due to the prolongation of life expectancy, interest in health promotion is increasing.
이에 따라 홍삼, 글루코사민, 비타민 등을 이용한 건강 기능성 식품의 수요가 늘고 있다.Accordingly, there is an increasing demand for health functional foods using red ginseng, glucosamine, and vitamins.
한편, 체리(cherry)는 장미과 벚나무속에 속하는 식물을 의미하며, 프루누스 파우시플로라 번지(Prunus pauciflora Bunge), 프루누스 아비움(Prunus avium), 프루누스 세라수스 L.(Prunus cerasus L.) 또는 프루누스 에푸사K.Schneider(Prunus effusa K. Schneider)의 학명을 갖는 식물 등을 포함한다. 붉은 빛을 나타내는 안토시아닌이 다량 함유되어 있어 항산화, 항염증, 항노화 효능을 가지고 있으며, 멜라토닌이 함유되어 있어 신체 피로를 감소시키고 건강을 유지하는데 도움을 줄 수 있다.On the other hand, cherry means a plant belonging to the genus Rosaceae Prunus, Prunus pauciflora Bunge, Prunus avium, Prunus cerasus L. or Prunus cerasus L. And plants having the scientific name of Prunus effusa K. Schneider. As it contains a large amount of red anthocyanins, it has antioxidant, anti-inflammatory, and anti-aging effects, and contains melatonin, which can help reduce body fatigue and maintain health.
이러한 체리는 보관성이 좋지 못해 사계절 내내 꾸준히 섭취하기에 어려움이 있었다. 이를 해소하기 위하여 체리를 착즙하여 주스로 음용하거나, 분말 형태로 가공하여 주스 형태로 음용하고 있다. These cherries have poor storage properties, making it difficult to consume them consistently throughout the four seasons. To solve this problem, cherries are juiced and consumed as juice, or processed into a powder form and consumed in a juice form.
또한, 흑삼은 홍삼을 가공하여서 되는 것으로, 홍삼 내에 다량으로 존재하는 진세노사이드 Rb, Rc, Rd, Re, Rg1 등이 가공과정 중 열분해 되어 진세노사이드 Rg2, Rg3, Rh 등으로 전환되며, 특히 진세노사이드 Rg3 함량이 강화된다. 상기 흑삼의 주요 효능으로는 자양·강장효과, 성기능 및 생식기능 부전 개선 효과, 항암효과, 간장기능 부전 개선 효과, 숙취해소 효과, 기생충 감염 방지효과, 진통·소염작용 등이 있는 것으로 알려져 있다.In addition, black ginseng is made by processing red ginseng, and ginsenosides Rb, Rc, Rd, Re, Rg1, etc., which are present in a large amount in red ginseng, are pyrolyzed during processing and converted into ginsenosides Rg2, Rg3, Rh, etc. Ginsenoside Rg3 content is enhanced. The main effects of black ginseng are known to have nourishing and tonic effects, improving sexual and reproductive dysfunction, anti-cancer effect, improving liver dysfunction, relieving hangovers, preventing parasite infection, and analgesic and anti-inflammatory effects.
종래 이러한 흑삼은 단독으로 사용되어 음료 조성물, 절편, 차, 건강보조식품 등으로 가공되어 왔다.Conventionally, such black ginseng has been used alone and processed into beverage compositions, slices, tea, health supplements, and the like.
그러나 종래 어디에서도 이러한 체리와 흑삼을 조합한 건강보조식품을 찾아볼 수 없었다.However, in the past, no other health supplement food that combines cherry and black ginseng has been found.
본 발명의 목적은 체리 농축액, 흑삼 농축액 및 콜라겐펩타이드를 조합하여 건강보조식품을 제조함으로써, 항산화, 항염 및 항노화 활성이 우수하고, 각종 영양성분 및 약용성분이 풍부한 건강보조식품 및 그 제조방법을 제공하는 데 있다.It is an object of the present invention to prepare a health supplement food by combining cherry concentrate, black ginseng concentrate and collagen peptide, which has excellent antioxidant, anti-inflammatory and anti-aging activity, and is rich in various nutrients and medicinal ingredients, and a method of manufacturing the same. To provide.
또한, 고혈압을 예방 및 개선하고, 숙면을 유도하여 삶의 질을 개선할 수 있는 건강보조식품 및 그 제조방법을 제공하는 데 있다.In addition, it is to prevent and improve hypertension, to induce a good night's sleep to improve the quality of life to provide a health supplement and a method of manufacturing the same.
상기한 목적을 달성하기 위한 본 발명의 건강보조식품은, 흑삼 농축액 8~12중량%, 피쉬콜라겐펩타이드 3~7중량%, 증점제 1~5중량% 및 잔부의 체리 농축액을 포함하는 것을 특징으로 한다.The health supplement of the present invention for achieving the above object is characterized in that it comprises 8 to 12% by weight of black ginseng concentrate, 3 to 7% by weight of fish collagen peptide, 1 to 5% by weight of thickener, and the balance of cherry concentrate. .
가죽나무 추출물 1~5중량% 및 에키네시아 추출물 1~5중량%를 더 포함하는 것을 특징으로 한다.It characterized in that it further comprises 1 to 5% by weight of leather tree extract and 1 to 5% by weight of echinacea extract.
산비장이 추출물 1~5중량%를 더 포함하는 것을 특징으로 한다.It is characterized in that it further comprises 1 to 5% by weight of mountain spleen extract.
본 발명에 의한 건강보조식품의 제조방법은, 체리 농축액과 흑삼 농축액을 혼합하는 단계와, 상기 혼합된 혼합액에 피쉬콜라겐펩타이드 및 증점제를 투입하여 혼합하는 단계와, 상기 혼합된 혼합물을 필터링하는 단계와, 상기 필터링된 혼합물을 92~94℃에서 살균하는 단계를 포함하며, 각 재료의 사용량은, 흑삼 농축액 8~12중량%, 피쉬콜라겐펩타이드 3~7중량%, 증점제 1~5중량% 및 잔부의 체리 농축액인 것을 특징으로 한다.The method of manufacturing a health supplement according to the present invention includes the steps of mixing cherry concentrate and black ginseng concentrate, adding fish collagen peptide and a thickener to the mixed mixture, and filtering the mixed mixture. , Including the step of sterilizing the filtered mixture at 92 ~ 94 ℃, the amount of each material, black ginseng concentrate 8 ~ 12% by weight,
상기 혼합된 혼합액에 피쉬콜라겐펩타이드 및 증점제를 투입하여 혼합하는 단계에서, 가죽나무 추출물, 에키네시아 추출물 및 산비장이 추출물을 더 혼합하되, 그 사용량은 가죽나무 추출물 1~5중량%, 에키네시아 추출물 1~5중량% 및 산비장이 추출물 1~5중량%이고, 상기 흑삼 농축액은, 흑삼에 물을 가하고, 70~100℃에서 5~24시간 추출하고, 감암농축한 것이고, 상기 피쉬콜라겐펩타이드는 피쉬콜라겐에 효소를 첨가하여 가수분해 반응시켜서 되는 것으로, 평균 분자량이 200Da~1,000Da이며, 상기 체리 농축액은 체리를 착즙하고, 감압농축한 것이며, 상기 가죽나무 추출물, 에키네시아 추출물 및 산비장이 추출물은, 물 및 탄소수 1 내지 4의 알코올 중 1종 이상을 용매로 하여 추출한 것임을 특징으로 한다. In the step of mixing by adding fish collagen peptide and a thickener to the mixed mixture, leather tree extract, echinacea extract, and mountain spleen extract are further mixed, the amount of which is 1-5% by weight of leather tree extract,
본 발명의 건강보조식품 및 그 제조방법에 의하면, 각종 영양성분 및 약용성분이 풍부하고, 항산화 및 항염 활성이 우수하며, 고혈압을 예방 및 개선하고, 숙면을 유도할 수 있어 섭취자의 건강을 도모할 수 있다는 장점이 있다.According to the health supplement and its manufacturing method of the present invention, it is rich in various nutrient and medicinal ingredients, has excellent antioxidant and anti-inflammatory activity, prevents and improves hypertension, and can induce a good night's sleep, thereby promoting the health of the ingestion. There is an advantage of being able to do it.
도 1 내지 도 4는 본 발명에 의한 시험에 2의 결과를 나타낸 그래프. 1 to 4 are graphs showing the results of the test according to the present invention.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에 의한 건강보조식품은, 각종 영양성분 및 약용성분이 풍부하여 섭취자의 건강유지에 도움을 주며, 항산화 및 항염 활성이 우수하다는 데 가장 큰 특징이 있다.The health supplement food according to the present invention is rich in various nutrient and medicinal ingredients to help maintain the health of the eater, and is characterized by its excellent antioxidant and anti-inflammatory activity.
상기와 같은 본 발명의 건강보조식품은, 흑삼 농축액 8~12중량%, 피쉬콜라겐펩타이드 3~7중량%, 증점제 1~5중량% 및 잔부의 체리 농축액을 포함하는 것을 특징으로 한다.The health supplement of the present invention as described above is characterized in that it comprises 8 to 12% by weight of black ginseng concentrate, 3 to 7% by weight of fish collagen peptide, 1 to 5% by weight of thickener, and the balance of cherry concentrate.
먼저, 상기 흑삼 농축액은 진세노사이드 Rg1, Rg2 및 Rg3 함량이 풍부한바, 본 발명에서는 Rg1, Rg2 및 Rg3 함량이 6mg/g 이상, 바람직하게는 6~30㎎/g인 흑삼 농축액을 사용한다. 이때, 상기 흑삼 농축액은 흑삼에 70~100℃의 물을 2~20중량배로 가하고, 5~24시간 추출한 후, 60~65℃ 정도에서 감압 농축하여 제조한다.First, the black ginseng concentrate is rich in ginsenosides Rg1, Rg2, and Rg3. In the present invention, a black ginseng concentrate having Rg1, Rg2 and Rg3 content of 6 mg/g or more, preferably 6 to 30 mg/g is used. At this time, the black ginseng concentrate is prepared by adding water at 70 to 100°C in 2 to 20 weight times to black ginseng, extracting for 5 to 24 hours, and then concentrating under reduced pressure at about 60 to 65°C.
상기 흑삼 농축액은 건강보조식품 내 8~12중량%로 포함되는데, 그 함량이 8중량% 미만이면 항산화 및 항염 활성이 충분하지 못하고, 12중량%를 초과하면 상대적으로 다른 성분의 함량이 줄어들게 되어 그 기능성이 저하되기 때문이다.The black ginseng concentrate is contained in 8 to 12% by weight in health supplements, and if the content is less than 8% by weight, the antioxidant and anti-inflammatory activity is not sufficient, and if it exceeds 12% by weight, the content of other ingredients is relatively reduced. This is because the functionality is deteriorated.
상기 피쉬콜라겐펩타이드는 피쉬콜라겐에 효소를 첨가하여 가수분해 반응시켜서 되는 것으로, 저분자량으로 인해 체내 흡수가 빠르다는 장점이 있다. 이러한 피쉬콜라겐펩타이드는 피부에 탄력을 부여하고, 노화를 방지하는 효과를 갖는다.The fish collagen peptide is obtained by hydrolysis reaction by adding an enzyme to fish collagen, and has the advantage of rapid absorption in the body due to a low molecular weight. These fish collagen peptides have the effect of imparting elasticity to the skin and preventing aging.
보다 구체적으로, 상기 피쉬콜라겐펩타이드는 피쉬콜라겐에 단백질분해효소인 콜라게나아제, 트립신, 파파인, 펩신 및 알칼라제로 이루어진 군 중 선택된 1종 이상을 투입하고, 50~70℃에서 2~24시간 가수분해 반응을 진행함으로써, 피쉬콜라겐펩타이드를 제조하는 것이다. 또한, 필요에 따라 정제 및 건조과정을 추가할 수 있다. 이러한 콜라겐펩타이드는 평균 분자량이 200~1,000Da로 체내에 빠른 흡수가 가능하게 되며, 가수분해로 인해 비린맛이 없어 섭취 역시 용이하다.More specifically, in the fish collagen peptide, at least one selected from the group consisting of proteases collagenase, trypsin, papain, pepsin and alcalase is added to fish collagen, and hydrolyzed at 50 to 70°C for 2 to 24 hours. By proceeding the decomposition reaction, fish collagen peptides are prepared. In addition, purification and drying processes can be added as needed. These collagen peptides have an average molecular weight of 200-1,000 Da, enabling rapid absorption into the body, and easy intake because there is no fishy taste due to hydrolysis.
상기 피쉬콜라겐펩타이드는 건강보조식품 내 3~7중량%로 포함된다.The fish collagen peptide is included in 3 to 7% by weight in the health supplement.
상기 증점제는 제품의 점도향상을 위한 것으로, 로커스트콩검, 카라기난, 타마린드검, 잔탄검 및 한천 중 1종 이상을 사용할 수 있다. 상기 증점제는 건강보조식품 내 1~5중량%로 포함된다.The thickener is for improving the viscosity of the product, and at least one of locust bean gum, carrageenan, tamarind gum, xanthan gum, and agar may be used. The thickener is included in 1 to 5% by weight in the health supplement.
상기 체리 농축액은 본 발명에 의한 건강보조식품의 주재료로서, 안토시아닌이 다량 함유되어 있어 우수한 항염, 항산화 및 항노화 활성을 부여할 뿐 아니라, 멜라토닌이 함유되어 있어 신체 피로를 감소시키고 건강을 유지하는데 도움을 준다. 또한, 숙면 역시 유도한다.The cherry concentrate is the main ingredient of the health supplement according to the present invention, and contains a large amount of anthocyanins to provide excellent anti-inflammatory, antioxidant and anti-aging activities, as well as melatonin to reduce body fatigue and help maintain health. Gives It also induces a good night's sleep.
이러한 체리 농축액은 체리를 착즙하고, 감압농축한 것으로, 건강보조식품 내 잔부로 포함된다. 이때, 체리는 그 종류를 제한하지 않는바, 윈터체리, 타트체리 등 다양한 종류를 모두 사용 가능하다. 본 발명에서는 타트체리 농축액을 사용한 것을 예로 들어 설명한다.This cherry concentrate is a cherry juice, concentrated under reduced pressure, and is included as a balance in health supplements. At this time, the type of cherry is not limited, and various types such as winter cherry and tart cherry can be used. In the present invention, a tart cherry concentrate will be described as an example.
상기와 같이, 흑삼 농축액, 피쉬콜라겐펩타이드, 증점제 및 체리 농축액을 포함하는 건강보조식품은 우수한 항염, 항산화 및 항노화 활성을 갖는다는 장점이 있다. 아울러, 상기한 성분들의 조화를 통해 수면유도 효과는 물론, 고혈압 개선의 효과 역시 갖는다는 장점이 있다.As described above, health supplements including black ginseng concentrate, fish collagen peptide, thickener and cherry concentrate have the advantage of having excellent anti-inflammatory, antioxidant and anti-aging activities. In addition, there is an advantage in that it has an effect of not only inducing sleep, but also improving hypertension through the harmony of the above ingredients.
다만, 상기 수면유도 효과 및 고혈압 개선의 효과를 더욱 증진시키기 위하여, 본 발명의 건강보조식품은 가죽나무 추출물 및 에키네시아 추출물을 더 포함할 수 있다.However, in order to further enhance the sleep-inducing effect and the effect of improving hypertension, the health supplement of the present invention may further include a leather tree extract and an echinacea extract.
상기 가죽나무(Ailanthus altissima)는 소태나무과(Simarou ba ceae)의 낙엽성 교목으로써 가중나무라고도 불리우며, 5,7-디하이드록시크롬-7-네오헤스페리도시드, 나린진 등의 플라보노이드 화합물과 3,4,5-트리메톡시페놀, p-코메릭 산, 바닐린, 바닐산 등의 페놀성 물질, 메로신, 탄닌 프로바펜, 아일란톤 등을 함유한다. 이러한 가죽나무의 추출물은 우수한 항산화 효과를 나타내어 피부 면역을 높여주는 것은 이미 알려진 사실이다. 본 발명에서는 항산화 효과를 개선하는 것은 물론, 상기 체리 농축액, 에키네시아 추출물, 흑삼 농축액 등과의 상호작용을 통해 우수한 고혈압 개선 및 수면유도 효과를 부여하는 것이다. The leather tree (Ailanthus altissima) is a deciduous tree of the family Simarou ba ceae and is also called a weight tree. It contains phenolic substances such as 4,5-trimethoxyphenol, p-comeric acid, vanillin, and vanillic acid, merosine, tannin propbafen, and alantone. It is a known fact that these extracts of leather wood exhibit excellent antioxidant effects and increase skin immunity. In the present invention, as well as improving the antioxidant effect, through the interaction with the cherry concentrate, echinacea extract, black ginseng concentrate, and the like, excellent hypertension improvement and sleep-inducing effects are provided.
상기 가죽나무의 추출물은 가죽나무의 잎에 10~50중량배의 물, 탄소수 1 내지 4의 알코올 중 1종 이상의 용매를 가하고, 30~100℃에서 3~12시간 추출, 여과하여 제조할 수 있으며, 필요에 따라 농축 및 건조할 수 있음은 당연하다. 아울러, 이외 천연물로부터 추출물을 제조하는 다양한 공지된 방법을 통해 제조할 수도 있음은 당연하다.The extract of the leather tree can be prepared by adding one or more solvents of 10 to 50 times by weight of water and alcohol having 1 to 4 carbon atoms to the leaves of the leather tree, extracting and filtering at 30 to 100°C for 3 to 12 hours, , It is natural that it can be concentrated and dried as needed. In addition, it is natural that it may be prepared through various known methods for preparing extracts from other natural products.
상기 가죽나무의 추출물은 그 효능을 고려할 때, 건강보조식품 내 1~5중량%로 포함됨이 바람직하다. When considering its efficacy, the extract of the leather tree is preferably contained in 1 to 5% by weight in a health supplement.
상기 에키네시아(Echinacea purpurea)는 오래전부터 북아메리카 원주민들에게 다양한 질환에 대한 전통 민간의약으로 사용되어온 것으로, 에키네시아속 식물은 9가지 종류가 알려져 있으며, 이중 3종(Echinacea angustifolia, Echinacea pallida, Echinacea purpurea)이 주로 의약적 목적으로 사용되고 있다. 본 발명에서는 상기 에키네시아의 종류를 제한하지 않는다. 상기 에키네시아 추출물은 항산화, 항균, 항바이러스, 항진균, 항염 효능이 있는 것으로 보고되고 있다. 에키네시아 추출물의 면역 기능은 과립구, 림프구, 단핵구 및 대식세포의 대사에 영향을 미치는 것으로 보고되고 있는데, 보고된 연구 결과에 의하면 에키네시아 추출물은 산화질소(Nitric Oxide)와 Il-1, Il-6, Il-8, Il-12, TNF-α와 같은 사이토카인의 분비를 촉진시키고 대식세포(macrophages)의 활성을 높여주어 면역력 강화에 도움을 주는 것으로 보고되고 있다. 에키네시아 추출물의 주된 활성 성분은 폴리페놀인 Caffeic Acid의 유도체로서, Caftaric acid, Chlorogenic acid, Cynarin, Echinacoside, Cichoric acid 와 같은 성분들이 있다. 본 발명에서는 항염 효과를 개선하는 것은 물론, 상기 체리 농축액, 가죽나무 추출물, 흑삼 농축액 등과의 상호작용을 통해 우수한 고혈압 개선 및 수면유도 효과를 부여하는 것이다. The Echinacea ( Echinacea purpurea) has long been used as a traditional folk medicine for various diseases by Native Americans in North America, and 9 types of Echinacea plants are known, of which 3 species ( Echinacea angustifolia, Echinacea pallida, Echinacea purpurea). ) Is mainly used for medicinal purposes. In the present invention, the type of echinacea is not limited. The echinacea extract is reported to have antioxidant, antibacterial, antiviral, antifungal, and anti-inflammatory effects. The immune function of echinacea extract has been reported to affect the metabolism of granulocytes, lymphocytes, monocytes and macrophages. According to the reported research results, echinacea extracts contain nitric oxide (Nitric Oxide) and Il-1, Il-6. , Il-8, Il-12, and promotes the secretion of cytokines such as TNF-α and increases the activity of macrophages (macrophages) has been reported to help strengthen immunity. The main active ingredient of echinacea extract is a derivative of Caffeic Acid, a polyphenol, and includes ingredients such as Caftaric acid, Chlorogenic acid, Cynarin, Echinacoside, and Cichoric acid. In the present invention, as well as improving the anti-inflammatory effect, through the interaction with the cherry concentrate, leather tree extract, black ginseng concentrate, and the like, excellent hypertension improvement and sleep-inducing effect are provided.
상기 에키네시아 추출물은, 에키네시아의 전초를 이용하여 상기 가죽나무 추출물과 동일한 방법으로 추출가능하며, 그 효능을 고려할 때, 건강보조식품 내 1~5중량%로 포함됨이 바람직하다. The echinacea extract can be extracted in the same manner as the leather tree extract using the echinacea outpost, and when considering its efficacy, it is preferably contained in 1 to 5% by weight in a health supplement.
또한, 본 발명의 건강보조식품은 산비장이 추출물을 더 포함할 수 있다. In addition, the health supplement food of the present invention may further include a sanbijang extract.
상기 산비장이(Serratuls coronate var. insularis Kitamura)는 코미공화국(러시아)에서 음식과 약용식물로 사용된다고 알려져 있다. 산비장이에 포함된 두 개의 주요 화합물은 에크디스테로이드(ecdysteroid) 계열의 20-히드록시엑디손(20-hydroxyecdysone) 및 25S 이노코스테론(25S inokosterone)인데, 소염(anti-inflammation) 및 항진정(anti-sedation) 등에 활성을 나타낸다고 알려져 있다. 본 발명에서 상기 산비장이 추출물을 더 포함할 경우 우수한 수면유도 효과를 갖는다.The mountain spleen (Serratuls coronate var. insularis Kitamura) is known to be used as a food and medicinal plant in the Republic of Komi (Russia). The two main compounds contained in the acid spleen are the ecdysteroid family of 20-hydroxyecdysone and 25S inokosterone, anti-inflammation and anti-sedation. It is known to exhibit activity such as anti-sedation). In the present invention, when the acid spleen extract is further included, it has an excellent sleep-inducing effect.
상기 산비장이 추출물은 산비장이의 뿌리 및 잎 중 1종 이상을 이용하여 상기 가죽나무 추출물과 동일한 방법으로 추출가능하며, 그 효능을 고려할 때, 건강보조식품 내 1~5중량%로 포함됨이 바람직하다. The Sanbijang extract can be extracted in the same manner as the leather tree extract using at least one of the roots and leaves of the Sanbijang, and considering its efficacy, it is preferable to be included in 1 to 5% by weight in the health supplement food. Do.
이하, 본 발명에 의한 건강보조식품의 제조방법에 대하여 상세히 설명한다. 이하, 그 제조방법을 설명함에 있어서, 앞서 건강보조식품에서 설명된 내용은 중복을 피하기 위하여 생략한다.Hereinafter, a method of manufacturing a health supplement food according to the present invention will be described in detail. Hereinafter, in describing the manufacturing method, the contents described in the health supplement food are omitted in order to avoid redundancy.
본 발명에 의한 건강보조식품의 제조방법은, 체리 농축액과 흑삼 농축액을 혼합하는 단계와, 상기 혼합된 혼합액에 피쉬콜라겐펩타이드 및 증점제를 투입하여 혼합하는 단계와, 상기 혼합된 혼합물을 필터링하는 단계와, 상기 필터링된 혼합물을 살균하는 단계를 포함하며, 상기 각 재료의 사용량은, 흑삼 농축액 8~12중량%, 피쉬콜라겐펩타이드 3~7중량%, 증점제 1~5중량% 및 잔부의 체리 농축액인 것을 특징으로 한다.The method of manufacturing a health supplement according to the present invention includes the steps of mixing cherry concentrate and black ginseng concentrate, adding fish collagen peptide and a thickener to the mixed mixture, and filtering the mixed mixture. , Including the step of sterilizing the filtered mixture, the amount of each material is 8-12% by weight of black ginseng concentrate, 3-7% by weight of fish collagen peptide, 1-5% by weight of thickener, and the balance of cherry concentrate. It is characterized.
보다 구체적으로, 액체원료인 체리 농축액과 흑삼 농축액을 혼합한다. 그리고 그 혼합액에 분말재료인 피쉬콜라겐펩타이드 및 증점제를 투입한 후, 믹싱기계를 이용하여 60~120분간 믹싱한다. More specifically, the liquid raw material cherry concentrate and black ginseng concentrate are mixed. Then, fish collagen peptides and thickeners, which are powder materials, are added to the mixture, and then mixed for 60 to 120 minutes using a mixing machine.
다음으로, 믹싱된 혼합물을 정밀여과필터(MF:Micro Filtration, 유체의 0.01~10㎛)를 이용하여 필터링한 후, 이를 고온살균시스템, 즉 93±1℃에서 10~20초간 살균한다. Next, after filtering the mixed mixture using a microfiltration filter (MF: Micro Filtration, 0.01 to 10 μm of fluid), it is sterilized in a high-temperature sterilization system, that is, 93±1° C. for 10 to 20 seconds.
그리고 살균 온도를 유지하면서 살균된 살균물을 내포장재에 충진한 후, 밀봉하고, 냉각하여 제조하는 것이다.Then, while maintaining the sterilization temperature, the sterilized sterilization material is filled in the inner packaging material, sealed, and cooled to manufacture.
이때, 가죽나물 추출물, 에키네시아 추출물 또는 산비장이 추출물을 더 투입할 경우, 상기 분말재료의 혼합과정에서 투입하여 믹싱한다.At this time, when the leather sprout extract, echinacea extract, or sanbijang extract is further added, it is added and mixed during the mixing process of the powdered material.
이하, 본 발명을 실시예를 통해 상세히 설명한다. Hereinafter, the present invention will be described in detail through examples.
(실시예 1)(Example 1)
타트체리를 착즙하여 착즙액을 제조하고, 이를 60℃로 감압농축하여 체리 농축액(고형분 60%)를 제조하였다. The tart cherries were juiced to prepare a juice solution, which was concentrated under reduced pressure at 60° C. to prepare a cherry concentrate (
6년근 홍삼을 90℃에서 100분간 증숙하고, 40℃에서 2시간 건조하였다. 이 과정을 9회 반복하여 흑삼을 제조하였다. 그리고 상기 제조된 흑삼에 80℃의 정제수 5중량배를 가하고, 90℃에서 10시간 추출하고, 60℃로 감압농축하여 흑삼 농축액(68brix)을 제조하였다. 제조된 흑삼 농축액의 진세노이드 Rg1, Rg2, Rg3 의 함량은 7mg/g이었다.Six-year-old red ginseng was steamed at 90°C for 100 minutes and dried at 40°C for 2 hours. This process was repeated 9 times to prepare black ginseng. Then, 5 weight times of purified water at 80°C was added to the prepared black ginseng, extracted for 10 hours at 90°C, and concentrated under reduced pressure at 60°C to prepare a black ginseng concentrate (68brix). The content of ginsenoids Rg1, Rg2, and Rg3 in the prepared black ginseng concentrate was 7mg/g.
피쉬콜라겐에 정제수를 4중량배로 가하고, 이에 펩신을 0.5%(w/w)의 양으로 첨가하여 55℃로 20시간 동안 가수분해시키고, 이를 분무건조하여 분자량이 200~1,000Da인 피쉬콜라겐펩타이드를 제조하였다. Purified water was added to fish collagen in an amount of 4 weight times, and pepsin was added in an amount of 0.5% (w/w), hydrolyzed at 55° C. for 20 hours, and spray-dried to obtain fish collagen peptides having a molecular weight of 200 to 1,000 Da. Was prepared.
그리고 상기 체리 농축액 82중량% 및 흑삼 농축액 10중량%을 혼합한 후, 피쉬콜라겐펩타이드 5중량% 및 증점제인 잔탄검 3중량%를 더 투입하여 1시간 동안 800rpm으로 교반하고, 정밀여과필터로 필터링하였다. 다음으로, 이를 고온살균시스템기계로 93℃에서 15초간 살균하고, 이를 내포장지에 충진하여 포장 후, 냉각하였다. And after mixing 82% by weight of the cherry concentrate and 10% by weight of the black ginseng concentrate, 5% by weight of fish collagen peptide and 3% by weight of xanthan gum as a thickener were further added, stirred at 800 rpm for 1 hour, and filtered through a microfiltration filter. . Next, it was sterilized at 93°C for 15 seconds with a high-temperature sterilization system machine, filled in an inner packaging paper, and cooled after packaging.
(실시예 2)(Example 2)
실시예 1과 동일하게 실시하되, 체리 농축액 76중량% 및 흑삼 농축액 10중량%을 혼합한 후, 피쉬콜라겐펩타이드 5중량%, 증점제인 잔탄검 3중량%, 가죽나무 추출물 2중량%, 에키네시아 추출물 2중량% 및 산비장이 추출물 2중량%를 더 혼합하였다. Conducted in the same manner as in Example 1, but after mixing 76% by weight of cherry concentrate and 10% by weight of black ginseng concentrate, 5% by weight of fish collagen peptide, 3% by weight of xanthan gum as a thickener, 2% by weight of leather tree extract, and echinacea extract 2% by weight and 2% by weight of the acid spleen extract were further mixed.
이때, 가죽나무 추출물은 가죽나무의 잎을, 에키네시아 추출물은 에키네시아(Echinacea angustifolia)의 전초를, 산비장이 추출물은 산비장이의 뿌리를 시료로 하여, 시료에 20 중량배의 증류수에 넣고 90~100℃에서 5시간 동안 열수추출하였다. 추출 후 와트만 2번 여과지로 여과하고, 0.45㎛ 필터로 한 번 더 여과한 후, 동결건조하여 제조하였다. At this time, the leather tree extract is the leaves of the leather tree, the echinacea extract is the outpost of Echinacea angustifolia , and the mountain spleen extract is the root of the mountain spleen. Hot water extraction was performed at ~100°C for 5 hours. After extraction, it was filtered through Whatman No. 2 filter paper, filtered once more with a 0.45 μm filter, and then freeze-dried to prepare.
(시험예 1)(Test Example 1)
실시예 1의 항산화 활성을 측정하였다.The antioxidant activity of Example 1 was measured.
시료의 항산화 활성(electron donation ability, EDA%)은 Blois의 방법을 변형하여 측정하였다 시료 2mL에 0.2mM의 DPPH(1,1-diphenyl-2-picryl hydrazyl) 0.5mL를 넣고 교반한 후, 30분간 방치한 다음 517nm에서 흡광도를 측정하였다. 전자공여 효과는 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다. 그리고 라디칼 소거 활성능은 다음과 같은 식에 의해 계산하고, 그 결과를 하기 표 1에 나타내었다. 대조구로는 BHT(합성산화방지제)를 사용하였다.Antioxidant activity (electron donation ability, EDA%) of the sample was measured by modifying the method of Blois. 0.5 mL of 0.2 mM DPPH (1,1-diphenyl-2-picryl hydrazyl) was added to 2 mL of the sample and stirred for 30 minutes. After standing, the absorbance was measured at 517 nm. The electron donating effect was expressed by the rate of decrease in absorbance between the addition and no addition of the sample solution. And the radical scavenging activity was calculated by the following equation, and the results are shown in Table 1 below. BHT (synthetic antioxidant) was used as a control.
라디칼소거활성능(%) = (1-시료첨가구의 흡광도/무첨가구의 흡광도)×100Radical scavenging activity (%) = (1-absorbance of sample added/absorbance of no additive) × 100
상기 표 1에서와 같이, DPPH radical scavenging activity 측정 결과에 따르면 본 발명의 실시예 1은 항산화활성이 우수함을 확인할 수 있었다. As shown in Table 1, according to the DPPH radical scavenging activity measurement result, it was confirmed that Example 1 of the present invention has excellent antioxidant activity.
(시험예 2)(Test Example 2)
상기 실시예 1의 시료의 항염 활성을 측정하였다. 이때, 시료는 동결건조하여 사용하였다. The anti-inflammatory activity of the sample of Example 1 was measured. At this time, the sample was lyophilized and used.
염증성 인자로는 Nitrite(혹은 일산화 산소), IL-1β(인터루킨-1베타, interleukin-1beta), IL-6(인터루킨-6, interleukin-6), TNF-α(종양괴사인자-알파, 혹은 tumor necrosis factor-alpha)를 사용하였다.Inflammatory factors include Nitrite (or oxygen monoxide), IL-1β (interleukin-1beta), IL-6 (interleukin-6, interleukin-6), and TNF-α (tumor necrosis factor-alpha, or tumor necrosis factor-alpha) was used.
시험방법은, 대식세포(macrophage)에 LPS(lipopolysaccharide)를 이용하여 염증을 유발하고, 여기에 시료를 처리하였을 때의 일반적인 염증 지표들이 억제되었는지를 조사하였다. 양성 대조군으로서는 DEX(Dexamethasone)을 비교약물로 사용하였다. In the test method, inflammation was induced by using LPS (lipopolysaccharide) in macrophages, and it was investigated whether general inflammatory indicators when treated with the sample were suppressed. As a positive control, DEX (Dexamethasone) was used as a comparative drug.
그리고 그 결과를 도 1 내지 도 4에 나타내었다.And the results are shown in FIGS. 1 to 4.
도 1 내지 도 4에서 확인할 수 있는 바와 같이, LPS로 염증 유도시 Nitrite가 크게 증가하였으나, 시료의 처리로 증가했던 Nitrite가 감소함을 확인할 수 있었으며, 도 2, 3, 4에서 확인할 수 있는 바와 같이, LPS로 인한 염증 유도시 cytokine이 크게 증가하였으나, 시료의 처리로 그 염증이 완화되는 것을 확인할 수 있었다.As can be seen in FIGS. 1 to 4, when inflammation was induced with LPS, Nitrite increased significantly, but it was confirmed that Nitrite increased by the treatment of the sample decreased. As can be seen in FIGS. 2, 3 and 4 , When inducing inflammation due to LPS, cytokine was significantly increased, but it was confirmed that the inflammation was alleviated by treatment of the sample.
따라서, 본 발명의 실시예 1은 염증성 인자들의 억제효과가 있으며, 항염증 성분으로 알려진 DEX와 유사한 수준의 억제 효과가 있을 것을 판단되었다.Accordingly, it was determined that Example 1 of the present invention has an inhibitory effect on inflammatory factors, and has an inhibitory effect at a level similar to that of DEX, which is known as an anti-inflammatory component.
(시험예 3)(Test Example 3)
실시예 1, 2에 따라 제조된 건강보조식품의 고혈압 개선 효과를 시험하였다.The effect of improving hypertension of the health supplements prepared according to Examples 1 and 2 was tested.
고혈압을 가진 10명의 성인남녀를 선별하고, 상기 피실험자들을 두 그룹으로 나누고, 혈압을 측정하였다. 그리고 한 그룹은 실시예 1의 건강보조식품을 6개월 동안 1일 1포(20g)씩 복용하게 하고, 다른 그룹은 실시예 2의 건강보조식품을 6개월 동안 1일 1포(20g)씩 복용하게 하였다. 그리고 6개월 후 피실험자들의 혈압을 측정하였다. 이때, 상기 혈압측정은 실험 전과 동일한 시간에 측정하였다. 그 결과를 하기 표 2에 나타내었다.Ten adult men and women with hypertension were selected, the subjects were divided into two groups, and blood pressure was measured. And one group was to take the dietary supplement of Example 1 1 packet (20g) a day for 6 months, and the other group took the dietary supplement of Example 2 1 packet (20g) a day for 6 months. I made it. And after 6 months, the blood pressure of the subjects was measured. At this time, the blood pressure was measured at the same time as before the experiment. The results are shown in Table 2 below.
상기 표 2에서와 같이, 상기 실시예 1 및 2의 건강보조식품을 섭취한 두 그룹 모두 혈압이 현저히 개선되는 것을 확인할 수 있었다.As shown in Table 2, it was confirmed that blood pressure was significantly improved in both groups ingesting the health supplements of Examples 1 and 2.
(시험예 4)(Test Example 4)
실시예 1 및 2의 건강보조식품의 수면 유도 성능을 확인하기 위해 불면증을 호소하는 성인 20명을 선정하여 두 그룹으로 나누고, 한 그룹에게는 실시예 1을 1주일 동안 매일 1포(20g)씩 복용하게 하고, 다른 그룹에게는 실시예 2를 1주일 동안 매일 1포(20g)씩 복용하게 한 후, 수면의 질이 향상되는 정도를 5점 평점법 (5: 아주 좋다, 4 : 좋다, 3 : 보통이다, 2 : 나쁘다, 1 : 아주 나쁘다)으로 평가하도록 하고, 그 평균을 아래 표 3에 기재하였다. 여기서, 수면의 질 평가는 ①정상적으로 잠드는지 여부, ②밤에 깨지 않고 숙면을 하는지 여부, ③아침에 잠자리에서 일어날 때 피곤함을 느끼는지 여부로 평가하도록 하였다. 대조군으로는 체리 농축액만을 사용하였으며, 실시예 1, 2와 동일하게 불면증을 호소하는 성인 10명을 선정하여 1주일 동안 매일 1포(20g)씩 복용하게 하였다.In order to check the sleep induction performance of the health supplements of Examples 1 and 2, 20 adults complaining of insomnia were selected and divided into two groups, and one group of Example 1 was taken daily for one week. Another group was given Example 2 to take 1 packet (20g) daily for 1 week, and then the degree of improvement in sleep quality was evaluated by a 5-point score method (5: very good, 4: good, 3: average) Is, 2: bad, 1: very bad), and the average is shown in Table 3 below. Here, the quality of sleep was evaluated by: ① whether you fall asleep normally, ② whether you sleep without waking up at night, and ③ whether you feel tired when you wake up in the morning. As a control, only cherry concentrate was used, and 10 adults complaining of insomnia were selected in the same manner as in Examples 1 and 2 to take 1 packet (20 g) daily for 1 week.
상기 표 3에서와 같이, 본 발명의 실시예 1 및 2는 밤에 깨지 않고 숙면을 취하는 정도 및 아침에 잠자리에서 일어날 때 피곤함을 느끼는지 정도에서 우수한 평가를 받았음을 확인할 수 있었다.As shown in Table 3, it was confirmed that Examples 1 and 2 of the present invention received excellent evaluations in terms of the extent to which they take a good night's sleep without waking up at night and whether they feel tired when they wake up from bed in the morning.
이상으로 본 발명의 특정한 부분을 상세히 기술하였는바, 당 업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.As described above, specific parts of the present invention have been described in detail, and it is clear that these specific techniques are only preferred embodiments for those of ordinary skill in the art, and the scope of the present invention is not limited thereto. Accordingly, it will be said that the substantial scope of the present invention is defined by the appended claims and their equivalents.
Claims (5)
상기 흑삼 농축액은 흑삼에 물을 가하고, 70~100℃에서 5~24시간 추출하고, 감압농축한 것이고,
상기 피쉬콜라겐펩타이드는 피쉬콜라겐에 효소를 첨가하여 가수분해 반응시켜서 되는 것으로, 평균 분자량이 200Da~1,000Da이며,
상기 체리 농축액은 체리를 착즙하고, 감압농축한 것이며,
상기 가죽나무 추출물, 에키네시아 추출물 및 산비장이 추출물은,
각 시료를 물 및 탄소수 1 내지 4의 알코올 중 1종 이상을 용매로 하여 추출한 것임을 특징으로 하는 건강보조식품.
Black ginseng concentrate 8-12% by weight, fish collagen peptide 3-7% by weight, leather tree extract 1-5% by weight, echinacea extract 1-5% by weight, mountain spleen extract 1-5% by weight, thickener 1-5% % And the balance of cherry concentrate,
The black ginseng concentrate is obtained by adding water to black ginseng, extracting for 5 to 24 hours at 70 to 100°C, and concentrating under reduced pressure,
The fish collagen peptide is obtained by hydrolysis reaction by adding an enzyme to fish collagen, and has an average molecular weight of 200 Da to 1,000 Da,
The cherry concentrate is obtained by juicing cherries and concentrating under reduced pressure,
The leather tree extract, echinacea extract and mountain spleen extract,
Health supplement, characterized in that each sample is extracted using one or more of water and alcohol having 1 to 4 carbon atoms as a solvent.
상기 혼합된 혼합액에 피쉬콜라겐펩타이드, 가죽나무 추출물, 에키네시아 추출물, 산비장이 추출물 및 증점제를 투입하여 혼합하는 단계와,
상기 혼합된 혼합물을 필터링하는 단계와,
상기 필터링된 혼합물을 92~94℃에서 살균하는 단계를 포함하며,
각 재료의 혼합량은,
상기 흑삼 농축액 8~12중량%, 피쉬콜라겐펩타이드 3~7중량%, 가죽나무 추출물 1~5중량%, 에키네시아 추출물 1~5중량%, 산비장이 추출물 1~5중량%, 증점제 1~5중량% 및 잔부의 체리 농축액이고,
상기 흑삼 농축액은 흑삼에 물을 가하고, 70~100℃에서 5~24시간 추출하고, 감압농축한 것이고,
상기 피쉬콜라겐펩타이드는 피쉬콜라겐에 효소를 첨가하여 가수분해 반응시켜서 되는 것으로, 평균 분자량이 200Da~1,000Da이며,
상기 체리 농축액은 체리를 착즙하고, 감압농축한 것이고,
상기 가죽나무 추출물, 에키네시아 추출물 및 산비장이 추출물은,
각 시료를 물 및 탄소수 1 내지 4의 알코올 중 1종 이상을 용매로 하여 추출한 것임을 특징으로 하는 건강보조식품의 제조방법.
Mixing the cherry concentrate and black ginseng concentrate,
Mixing by adding fish collagen peptide, leather tree extract, echinacea extract, mountain spleen extract and a thickener to the mixed solution,
Filtering the mixed mixture,
Including the step of sterilizing the filtered mixture at 92 ~ 94 ℃,
The mixing amount of each material is,
The black ginseng concentrate 8 to 12% by weight, fish collagen peptide 3 to 7% by weight, leather tree extract 1 to 5% by weight, echinacea extract 1 to 5% by weight, mountain spleen extract 1 to 5% by weight, thickener 1 to 5 % By weight and the balance of cherry concentrate,
The black ginseng concentrate is obtained by adding water to black ginseng, extracting for 5 to 24 hours at 70 to 100°C, and concentrating under reduced pressure,
The fish collagen peptide is obtained by hydrolysis reaction by adding an enzyme to fish collagen, and has an average molecular weight of 200 Da to 1,000 Da,
The cherry concentrate is juiced and concentrated under reduced pressure,
The leather tree extract, echinacea extract and mountain spleen extract,
A method for producing a health supplement, characterized in that each sample is extracted by using one or more of water and alcohol having 1 to 4 carbon atoms as a solvent.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200104750A KR102235623B1 (en) | 2020-08-20 | 2020-08-20 | Health care food and method for manufacturing thereof |
PCT/KR2021/010930 WO2022039480A1 (en) | 2020-08-20 | 2021-08-18 | Dietary supplement comprising black ginseng concentrate and cherry concentrate, and method for preparing same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200104750A KR102235623B1 (en) | 2020-08-20 | 2020-08-20 | Health care food and method for manufacturing thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102235623B1 true KR102235623B1 (en) | 2021-04-06 |
Family
ID=75472727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200104750A Active KR102235623B1 (en) | 2020-08-20 | 2020-08-20 | Health care food and method for manufacturing thereof |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102235623B1 (en) |
WO (1) | WO2022039480A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022039480A1 (en) * | 2020-08-20 | 2022-02-24 | (주)블랙진생코리아 | Dietary supplement comprising black ginseng concentrate and cherry concentrate, and method for preparing same |
KR20230072141A (en) * | 2021-11-17 | 2023-05-24 | 박철웅 | manufacturing method of dried or semi-dried squid using citron, plum |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116584661A (en) * | 2023-06-14 | 2023-08-15 | 北京中研康华生物科技有限公司 | Small molecule complex peptide formula, usage and consumption method for body function repair |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020024127A (en) * | 2002-01-26 | 2002-03-29 | 손영석 | Drinks containing substances that become medicine |
KR20070054645A (en) * | 2004-07-28 | 2007-05-29 | 카아길, 인코포레이팃드 | Physiologically active composition based on collagen |
KR20090052932A (en) * | 2007-11-22 | 2009-05-27 | 녹차원(주) | Tea using fruit and leaves of vitamin tree and its manufacturing method |
KR101302513B1 (en) | 2011-07-08 | 2013-09-03 | 이현실 | Worn red ginseng or black ginseng dried slices and preparation method thereof and red ginseng or black ginseng extract tea prepared using the same |
KR101563310B1 (en) | 2011-06-23 | 2015-10-26 | 내처럴 메디슨 인스티튜트 오브 제지앙 양솅탕 컴퍼티 리미티드 | An acerola cherry powder and a method for producing the same |
KR20170137703A (en) * | 2015-01-16 | 2017-12-13 | 웰드링스 엘티디 | Beverage with collagen and additional additives |
KR102014824B1 (en) | 2018-05-09 | 2019-08-28 | 주식회사 진생바이팜 | Health food composition for vascular relaxation and anti-thrombotic effects comprising Black Ginseng Radix, Salviae Miltiorrhizae Radix, Leonuri Herba and Cnidii Rhizoma |
KR102107387B1 (en) | 2018-09-17 | 2020-05-08 | 주식회사 진생바이팜 | Beverage composition for treating hangover comprising black ginseng extact |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101761518B1 (en) * | 2016-09-13 | 2017-07-26 | 최선임 | dried Sweet potato cretins manufacturing Method |
KR102235623B1 (en) * | 2020-08-20 | 2021-04-06 | (주)블랙진생코리아 | Health care food and method for manufacturing thereof |
-
2020
- 2020-08-20 KR KR1020200104750A patent/KR102235623B1/en active Active
-
2021
- 2021-08-18 WO PCT/KR2021/010930 patent/WO2022039480A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020024127A (en) * | 2002-01-26 | 2002-03-29 | 손영석 | Drinks containing substances that become medicine |
KR20070054645A (en) * | 2004-07-28 | 2007-05-29 | 카아길, 인코포레이팃드 | Physiologically active composition based on collagen |
KR20090052932A (en) * | 2007-11-22 | 2009-05-27 | 녹차원(주) | Tea using fruit and leaves of vitamin tree and its manufacturing method |
KR101563310B1 (en) | 2011-06-23 | 2015-10-26 | 내처럴 메디슨 인스티튜트 오브 제지앙 양솅탕 컴퍼티 리미티드 | An acerola cherry powder and a method for producing the same |
KR101302513B1 (en) | 2011-07-08 | 2013-09-03 | 이현실 | Worn red ginseng or black ginseng dried slices and preparation method thereof and red ginseng or black ginseng extract tea prepared using the same |
KR20170137703A (en) * | 2015-01-16 | 2017-12-13 | 웰드링스 엘티디 | Beverage with collagen and additional additives |
KR102014824B1 (en) | 2018-05-09 | 2019-08-28 | 주식회사 진생바이팜 | Health food composition for vascular relaxation and anti-thrombotic effects comprising Black Ginseng Radix, Salviae Miltiorrhizae Radix, Leonuri Herba and Cnidii Rhizoma |
KR102107387B1 (en) | 2018-09-17 | 2020-05-08 | 주식회사 진생바이팜 | Beverage composition for treating hangover comprising black ginseng extact |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022039480A1 (en) * | 2020-08-20 | 2022-02-24 | (주)블랙진생코리아 | Dietary supplement comprising black ginseng concentrate and cherry concentrate, and method for preparing same |
KR20230072141A (en) * | 2021-11-17 | 2023-05-24 | 박철웅 | manufacturing method of dried or semi-dried squid using citron, plum |
KR102729961B1 (en) * | 2021-11-17 | 2024-11-14 | 박철웅 | manufacturing method of dried or semi-dried squid using citron, plum |
Also Published As
Publication number | Publication date |
---|---|
WO2022039480A1 (en) | 2022-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102235623B1 (en) | Health care food and method for manufacturing thereof | |
US9950024B2 (en) | Traditional Chinese medicine composition and the use thereof | |
CN103989219A (en) | Blueberry-containing composite nutritional syrup and processing method thereof | |
KR102262306B1 (en) | Composition for relieving premenstrual syndrome and menstrual pain | |
CN105112265A (en) | Health-care fig wine and preparation method thereof | |
CN105368688A (en) | Grape vinegar | |
CN104560576B (en) | Maca health preserving wine and preparation method thereof | |
CN104256782B (en) | A kind of root of kudzu vine mountain Qi beverage and preparation method thereof | |
CN112913996A (en) | Rosa roxburghii Tratt liquid for improving sleep quality and preparation method thereof | |
CN106798214A (en) | A kind of hippophae rhamnoides beverage and preparation method thereof | |
CN108041357B (en) | Natural plant multifunctional nutritional beverage and preparation method thereof | |
CN103103098A (en) | Juice type healthcare yellow wine beverage and preparation method thereof | |
CN102599591A (en) | Chrysanthemum beverage | |
CN112913995A (en) | Roxburgh rose liquid for improving immunity and preparation method thereof | |
CN111802542A (en) | Cranberry plant beverage containing prebiotics and preparation method thereof | |
US8524293B1 (en) | Method for producing a red grape tea-like composition | |
CN105166294A (en) | Composite functional purple sweet potato leaf candies and preparation method thereof | |
KR20080033717A (en) | Supplementary food composition and its manufacturing method using honey and herbal medicine | |
CN102787048A (en) | Brewing method of nigrum fruit health care wine | |
BG2729U1 (en) | Alcoholic beverage | |
CN104893910A (en) | Compound alfalfa Chinese herb healthcare wine with spleen-clearing and stomach-invigorating functions | |
KR20190125616A (en) | Method for producing inner beauty beverage using Chrysanthemum zawadskii and fermeted Rhus verniciflua | |
KR102491278B1 (en) | Food composition including red ginseng and arginine, and a method of preparing the same | |
KR101910823B1 (en) | Anti-stress Composition Using Ginsenoside Compound K | |
RU2833055C1 (en) | Method of producing balsam with hydrobionts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20200820 |
|
PA0201 | Request for examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20200820 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20201204 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20210326 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20210329 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20210330 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |